FULCRUM THERAPEUTICS, INC. (FULC) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -85.00M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-85.00M | (m) |
| 2026-03-31 | (m) | $-76.12M | (m) |
| 2025-12-31 | (m) | $-74.88M | (m) |
| 2025-09-30 | (m) | $-71.11M | (m) |
| 2025-06-30 | (m) | $-73.22M | (m) |
| 2025-03-31 | (m) | $-510.00K | (m) |
| 2024-12-31 | (m) | $-9.72M | (m) |
| 2024-09-30 | (m) | $-17.91M | (m) |
| 2024-06-30 | (m) | $-20.23M | (m) |
| 2024-03-31 | (m) | $-99.43M | (m) |
| 2023-12-31 | (m) | $-97.33M | (m) |
| 2023-09-30 | (m) | $-98.71M | (m) |
| 2023-06-30 | (m) | $-98.44M | (m) |
| 2023-03-31 | (m) | $-108.72M | (m) |
| 2022-12-31 | (m) | $-109.87M | (m) |
| 2022-09-30 | (m) | $-107.22M | (m) |
| 2022-06-30 | (m) | $-104.20M | (m) |
| 2022-03-31 | (m) | $-89.78M | (m) |
| 2021-12-31 | (m) | $-80.85M | (m) |
| 2021-09-30 | (m) | $-75.08M | (m) |
| 2021-06-30 | (m) | $-73.33M | (m) |
| 2021-03-31 | (m) | $-69.37M | (m) |
| 2020-12-31 | (m) | $-70.82M | (m) |
| 2020-09-30 | (m) | $-69.22M | (m) |
| 2020-06-30 | (m) | $-66.80M | (m) |
| 2020-03-31 | (m) | $-64.29M | (m) |
| 2019-12-31 | (m) | $-82.68M | (m) |
| 2019-09-30 | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) |
| 2018-12-31 | (m) | $-32.59M | (m) |
| 2018-09-30 | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |